Critical review of prostate cancer predictive tools (Q34104562)

31 July 2017

1 reference

title

Critical review of prostate cancer predictive tools (English)

1 reference

31 July 2017

1 reference

Andrew J Vickers

3

0 references

Pierre I Karakiewicz

series ordinal

4

object named as

Pierre I Karakiewicz

1 reference

31 July 2017

1

Shahrokh F Shariat

1 reference

31 July 2017

2

Michael W Kattan

1 reference

31 July 2017

Peter T Scardino

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

31 July 2017

1 reference

31 July 2017

volume

5

1 reference

31 July 2017

issue

10

1 reference

31 July 2017

page(s)

1555-1584

1 reference

31 July 2017

cites work

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

An updated catalog of prostate cancer predictive tools

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Assessing individual risk for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Development and external validation of an extended repeat biopsy nomogram

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Decision curve analysis: a novel method for evaluating prediction models

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Development and external validation of an extended 10-core biopsy nomogram

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Primer: using decision analysis to improve clinical decision making in urology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Validation of a nomogram for predicting positive repeat biopsy for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

The use of artificial neural network analysis to improve the predictive accuracy of prostate biopsy in the Japanese population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Comparison of Cox Regression With Other Methods for Determining Prediction Models and Nomograms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

A neurocomputational model for prostate carcinoma detection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤ 10 ng/mL

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

A Nomogram For Predicting a Positive Repeat Prostate Biopsy in Patients With a Previous Negative Biopsy Session

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

An artificial neural network to predict the outcome of repeat prostate biopsies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Internal and external validation of predictive models: a simulation study of bias and precision in small samples

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Predicting the outcome of prostate biopsy in a racially diverse population: a prospective study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Comparisons of nomograms and urologists' predictions in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Novel artificial neural network for early detection of prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Prediction of prostate carcinoma stage by quantitative biopsy pathology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

The problem of cutoff levels in a screened population: appropriateness of informing screenees about their risk of having prostate carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Estimation of prostate cancer probability by logistic regression: free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Natural history of progression after PSA elevation following radical prostatectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Evaluation of prostAsure index in the detection of prostate cancer: a preliminary report

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Identification of intermediate-risk prostate cancer patients treated with radiotherapy suitable for neoadjuvant hormone studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Artificial Neural Networks in the Diagnosis and Prognosis of Prostate Cancer: A Pilot Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Recall and attitudes in patients with prostate cancer.

5 July 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Heuristics and biases: selected errors in clinical reasoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Game relativity: how context influences strategic decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Neural networks, logistic regression, and calibration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Can nomograms be superior to other prediction tools?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Nomograms provide improved accuracy for predicting survival after radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Radical prostatectomy nomograms in black American men: accuracy and applicability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Model to predict prostate biopsy outcome in large screening population with independent validation in referral setting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Neuro-fuzzy system for prostate cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

An enhanced prognostic system for clinically localized carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Determinants of Prostate Cancer Specific Survival Following Radiation Therapy During the Prostate Specific Antigen Era

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Natural History of Early, Localized Prostate Cancer

21 January 2018

2 references

https://api.crossref.org/works/10.2217%2FFON.09.121

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis

28 October 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Combined Endorectal and Phased-Array MRI in the Prediction of Pelvic Lymph Node Metastasis in Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.121

Cancer control with radical prostatectomy alone in 1,000 consecutive patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933457

Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer

28 October 2018

1 reference

12 December 2020

How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor

1 reference

12 December 2020

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

1 reference

12 December 2020

Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers

1 reference

12 December 2020

Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma

1 reference

12 December 2020

Site specific predictors of positive margins at radical prostatectomy: an argument for risk based modification of technique

1 reference

12 December 2020

Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy

1 reference

12 December 2020

PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level

1 reference

12 December 2020

Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening

1 reference

12 December 2020

Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy

1 reference

12 December 2020

Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy

1 reference

12 December 2020

A Nomogram to Predict Seminal Vesicle Invasion by the Extent and Location of Cancer in Systematic Biopsy Results

1 reference

12 December 2020

Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer

1 reference

12 December 2020

Prediction of capsular perforation and seminal vesicle invasion in prostate cancer

1 reference

12 December 2020

Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer

1 reference

12 December 2020

Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer

1 reference

12 December 2020

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology

1 reference

12 December 2020

Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection

1 reference

12 December 2020

Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel

1 reference

12 December 2020

Development and internal validation of preoperative transition zone prostate cancer nomogram

1 reference

12 December 2020

Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy

1 reference

12 December 2020

Predicting Nonsentinel Node Status After Positive Sentinel Lymph Biopsy for Breast Cancer: Clinicians Versus Nomogram

1 reference

12 December 2020

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer

1 reference

12 December 2020

Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy

1 reference

12 December 2020

An analysis of risk factors for biochemical progression in patients with seminal vesicle invasion: validation of Kattan's nomogram in a pathological subgroup

1 reference

12 December 2020

Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer

1 reference

12 December 2020

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

12 December 2020

Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer

1 reference

12 December 2020

Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation

1 reference

12 December 2020

Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy

1 reference

12 December 2020

Predicting life expectancy in men with clinically localized prostate cancer

1 reference

12 December 2020

Analysis of Risk Factors Associated with Prostate Cancer Extension to the Surgical Margin and Pelvic Node Metastasis at Radical Prostatectomy

1 reference

12 December 2020

External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy

1 reference

12 December 2020

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

12 December 2020

A Nomogram Predicting 10-Year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate Cancer

1 reference

12 December 2020

Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer

1 reference

12 December 2020

A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men

1 reference

12 December 2020

Nomograms. Introduction

1 reference

12 December 2020

International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy

1 reference

12 December 2020

Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer

1 reference

12 December 2020

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

1 reference

12 December 2020

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men

1 reference

12 December 2020

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

1 reference

12 December 2020

The impact of co-morbidity on life expectancy among men with localized prostate cancer

1 reference

12 December 2020

The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

1 reference

12 December 2020

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy

1 reference

12 December 2020

Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients

1 reference

12 December 2020

A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer

1 reference

12 December 2020

Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study

1 reference

12 December 2020

Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma

1 reference

12 December 2020

Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications

1 reference

12 December 2020

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

12 December 2020

A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer

1 reference

12 December 2020

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium

1 reference

12 December 2020

Heuristic and linear models of judgment: matching rules and environments

1 reference

12 December 2020

A nomogram predicting long-term biochemical recurrence after radical prostatectomy

1 reference

12 December 2020

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

1 reference

12 December 2020

Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer

1 reference

12 December 2020

Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era

1 reference

12 December 2020

The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer

1 reference

12 December 2020

Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy

1 reference

12 December 2020

Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy

1 reference

12 December 2020

A catalog of prostate cancer nomograms

1 reference

12 December 2020

Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.2217/FON.09.121

1 reference

31 July 2017

1 reference

31 July 2017

1 reference